脑出血后不同时间脑脊液中可溶性白细胞介素6受体的变化(英文)  

Change of soluble interleukin 6 receptor in cerebral spinal fluid of different time after cerebral hemorrhage

作　　者：李介华[1] 李伟明[2] 徐国祥[3] 冯建容[2] 徐辉[1] 

机构地区：[1]暨南大学医学院第五附属医院暨清远市人民医院检验科,广东省清远市511500 [2]暨南大学医学院第五附属医院暨清远市人民医院神经内科,广东省清远市511500 [3]暨南大学医学院第五附属医院暨清远市人民医院神经外科,广东省清远市511500

出　　处：《中国临床康复》2004年第34期7850-7852,共3页Chinese Journal of Clinical Rehabilitation

基　　金：广东省医学科研基金(A2000808);和清远市医学科研计划项目(200013)~~

摘　　要：背景:在脑血管病脑损伤中有许多细胞因子的参与,而白细胞介素6(interleukin-6,IL-6)被认为在中枢神经系统中具有神经保护和神经营养作用,而脑出血急性期脑脊液可溶性IL-6受体(solubleinterleukin-6re-ceptor,sIL-6R)的研究国内外报道较少。目的:研究脑出血急性期脑脊液中sIL-6R变化与继发性脑损伤的关系。设计:病例对照研究。单位:暨南大学医学院第五附属医院检验科、神经外科、神经内科联合进行课题研究。对象:从1999-01/2003-12收治的脑出血患者627例中,选择经临床诊断和CT证实的自发性脑出血后48h内入院的患者,并排除创伤性脑出血和其他脑血管疾病,符合以上标准的32例患者作为研究对象(脑出血组),其中脑实质出血破入脑室者23例,单纯脑实质出血者7例,单纯脑室出血2例。13例同期住院的非神经系统疾病就诊者为对照组。方法:患者于入院后2d内腰穿取脑脊液2mL离心沉淀取上清液放-80℃超低温冰箱保存待测,12例患者出血后第1,2,3,5,10～13天进行动态观察。采用酶联免疫吸附试验(ELISA)测定对照组和脑出血患者脑脊液中sIL-6R含量。主要观察指标:对照组和脑出血患者脑脊液中sIL-6R含量。结果:13例对照组和32例脑出血急性期患者脑脊液中sIL-6R含量分别为(380.54±93.05)ng/L,(1220.18±878.71)ng/L,两者之间差?BACKGROUND:There are many cell factors involved in cerebrovascular diseases and cerebral damages.Interleukin 6(IL 6) has been widely believed that it can protect and nourish nerves in central nervous system.However,there are few literatures at home and abroad regarding soluble interleukin 6 receptor(sIL 6R) in cerebral spinal fluid in the acute stage of cerebral hemorrhage. OBJECTIVE:To explore the change of sIL 6R in cerebral spinal fluid in acute stage of cerebral hemorrhage as well as its relationship with secondary cerebral injury. DESIGN:Case control study. SETTING:Department of dicimasia, neurosurgery and neurology, the Fifth Affiliated Hospital of Medical College of Jinan University. PARTICIPANTS:There were 627 patients with cerebral hemorrhage treated during January 1999 to December 2003.Selective criteria: Patients with spontaneous cerebral hemorrhage confirmed by clinical diagnosis and CT examination and admitted into hospital within 48 hours;traumatic cerebral hemorrhage and other cerebrovascular diseases have been excluded.A total of 32 patients met the above criteria were chosen as hemorrhage group,among which there were 23 patients with hemorrhage of cerebral substance breaking into ventricle,7 patients with simply cerebral substance hemorrhage and 2 patients with simply ventricular hemorrhage. Thirteen patients admitted into hospital with non nervous system diseases were selected as control group. METHODS:2 mL cerebral spinal fluid was collected from patients by epidural puncture within 2 days after admission and centrifugated and deposited to collect supernate. The specimens were put into 80 ℃ultra low temperature freezer to store. Dynamic observation of 12 patients was conducted in the 1st,2nd,3rd,5th and 10th to 13th day.ELISA was used to assay the content of sIL 6R in cerebral spinal fluid of control group and hemorrhage patients. MAIN OUTCOME MEASURES:The content of sIL 6R in cerebral spinal fluid of patients in both control group and hemorrhage group. RESULTS:The content of

关 键 词：脑出血 脑脊液 可溶性白细胞介素6受体 急性期 神经保护 

分 类 号：R743.34[医药卫生—神经病学与精神病学]